|
Estrada C., Tarragon E., Kelley J.B., Lopez D., Gil-Martínez A.L., Villalba E.F., Herrero M.T. Transcranial magnetic stimulation on rodent models. CNS and Neurological Disorders Drug Targets. 1 September 2016. 15:756-764. 10.2174/1871527315666160518125341
AÑO: 2016; IF: 2.506
|
27063016
|
Jiménez-Jiménez F.J., Alonso-Navarro H., Herrero M.T., Garcia-Martin E., Agundez J.A.G. An update on the role of nitric oxide in the neurodegenerative processes of parkinson's disease. Current Medicinal Chemistry. 1 July 2016. 23:2666-2679. 10.2174/0929867323666160812150737
AÑO: 2016; IF: 3.249
|
|
Estrada C, Fernández-Gómez FJ, López D, Gonzalez-Cuello A, Tunez I, Toledo F, Blin O, Bordet R, Richardson JC, Fernandez-Villalba E, Herrero MT. Transcranial magnetic stimulation and aging: Effects on spatial learning and memory after sleep deprivation in Octodon degus. Neurobiol Learn Mem. 2015 Nov;125:274-81. doi: 10.1016/j.nlm.2015.09.011. Epub 2015 Oct 20. PubMed PMID: 26463507.
AÑO: 2015; IF: 3.244
|
|
Urgoitia G, SanMartin R, Herrero MT, Domínguez E. An outstanding catalyst for the oxygen-mediated oxidation of arylcarbinols, arylmethylene and arylacetylene compounds. Chem Commun (Camb). 2015 Mar 21;51(23):4799-802. doi: 10.1039/c5cc00750j. PubMed PMID: 25692654.
AÑO: 2015; IF: 6.29
|
|
Herrero MT, Estrada C, Maatouk L, Vyas S. Inflammation in Parkinson's disease: role of glucocorticoids. Front Neuroanat. 2015 Apr 2;9:32. doi: 10.3389/fnana.2015.00032. eCollection 2015. Review. PubMed PMID: 25883554; PubMed Central PMCID: PMC4382972.
AÑO: 2015; IF: 3.152
|